Table 1.

Univariate cox proportional hazards analysis of clinical parameters and m6A risk score level of glioblastoma (GBM) patients in the training set and validation set.

Variables		Training set		Validation set
		Univariate analysis		Univariate analysis
		HR(95%CI)	P-value	HR(95%CI)	P-value
Age group	Younger vs old	0.41(0.286-0.61)	6.7e-06	1.24(0.87-1.76)	0.217
CIMP status	G-CIMP vs NON	1.63(0.96- 2.78)	0.068	/	/
Gender	Male vs Female	1.04(0.78- 1.40)	0.764	0.91(0.63-1.32)	0.642
Subtype	NE+PE vs CL+ME	1.15(0.80- 1.64)	0.437	/	/
m6Arisk group	Low vs High	0.48(0.34- 0.70)	8.67e-05	0.53 (0.32-0.86)	0.0103
Radiotherapy	Yes vs No	/	/	0.51(0.26-1.02)	0.05
Chemotherapy	Yes vs No	/	/	0.59(0.30-1.18)	0.139
IDH status	Wildtype vs Mutant	/	/	1.45(0.83-2.53)	0.190
1p19q status	Non vs Codel	/	/	1.20(0.48-2.97)	0.690

Bold values are statistically significant.